Prevalence of HPV (Human Papilloma Virus) and HPV Vaccination Among Victims of Sexual Violence

Not yet recruitingOBSERVATIONAL

Enrollment

200

Participants

Timeline

Start Date

February 29, 2024

Primary Completion Date

February 28, 2025

Study Completion Date

February 28, 2026

Conditions

Human Papilloma VirusSexual AssaultSex Abuse

Interventions

DIAGNOSTIC_TEST

smears

PCR smears for HPV testing will be performed

All Listed Sponsors

collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

Centre Hospitalier Universitaire Saint Pierre

OTHER

NCT06255938 - Prevalence of HPV (Human Papilloma Virus) and HPV Vaccination Among Victims of Sexual Violence | Biotech Hunter | Biotech Hunter